Submission Details
| 510(k) Number | K962866 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 23, 1996 |
| Decision Date | August 23, 1996 |
| Days to Decision | 31 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K962866 is an FDA 510(k) clearance for the OPUS HLH, a Radioimmunoassay, Luteinizing Hormone (Class I — General Controls, product code CEP), submitted by Behring Diagnostics, Inc. (Westwood, US). The FDA issued a Cleared decision on August 23, 1996, 31 days after receiving the submission on July 23, 1996. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1485.
| 510(k) Number | K962866 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 23, 1996 |
| Decision Date | August 23, 1996 |
| Days to Decision | 31 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CEP — Radioimmunoassay, Luteinizing Hormone |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 862.1485 |